Asia-Pacific projected as fastest-growing medical-tourism region at 15.4% CAGR (2026-2033)

Coherent Market Insights projects the global medical-tourism market will grow at a 12.2% compound annual rate between 2026 and 2033 — and projects Asia-Pacific specifically to grow at 15.4% over the same window, putting the region roughly a quarter faster than the global average by the same firm's own numbers.¹ That's not a coincidence of one good year; it's the compounding result of at least four Asian governments — India, Malaysia, Thailand, and Vietnam — simultaneously running named, funded international-patient programs in the same three-year window, each with its own patient-volume and revenue figures to show for it.

The region in one table

Every figure above comes from a different report using a different counting method — visa-category arrivals, total healthcare-traveller counts, and revenue estimates aren't interchangeable, and the table deliberately leaves cells blank rather than filling them with a number a source didn't actually publish.

India: the biggest raw numbers, and the biggest internal spread

India illustrates just how much a single country's own reporting can disagree with itself depending on which statistic gets quoted. Coherent Market Insights and a 2026 India travel-budget writeup both cite 644,000 (644,387, precisely, per Coherent) foreign tourist arrivals specifically for medical treatment in 2024.¹² The same budget writeup separately states that roughly 2 million patients visit India annually from more than 78 countries — a figure more than three times higher, almost certainly because it counts patients entering under other visa categories or captures a wider "medical value travel" definition than the narrower medical-visa-arrival count.² Within the medical-visa-specific figure, the concentration is stark: 482,336 of the reported medical-purpose visitors in 2024 — about 70% — came from Bangladesh alone, meaning the "India medical tourism" headline number is disproportionately a story about proximity-driven Bangladeshi patients rather than a globally distributed patient base.²

On the policy side, India's Union Budget 2026 proposed five regional medical hubs built in partnership with state governments and the private sector, each combining AYUSH (traditional-medicine) centers, diagnostic infrastructure, and post-care rehabilitation facilities, alongside continued e-Medical visa access now extended to 167-plus countries.¹² The current industry is valued at roughly $12 billion in 2026, with the same source projecting it could exceed $35 billion by 2027 — a jump that would require sustained growth well above even the region's already-elevated 15.4% CAGR, and should be read as an optimistic industry projection rather than a settled forecast.²

How reliable are India's own numbers?

Pull on this thread further and India's headline figures get genuinely hard to pin down. Ratings agency Crisil, cited by the India Brand Equity Foundation, projected 7.3 million medical tourists would visit India in calendar year 2024 — more than eleven times the 644,000 figure Coherent Market Insights and the Union Budget writeup both cite as 2024's foreign medical-purpose arrivals.⁶ That gap is too large to be rounding or methodology noise; it almost certainly reflects Crisil counting a much broader "medical value travel" category (potentially including wellness, Ayurveda, and IVF tourism, and possibly domestic-adjacent spending) against the narrower Bureau of Immigration-style count of foreign nationals arriving specifically on medical-purpose visas.

The oft-repeated "2 million patients a year from 78-plus countries" figure adds a third data point — and a warning sign about how these statistics circulate. A Wikipedia citation traces a nearly identical claim ("approximately 2 million patients visit India each year from 78 countries... generating $6 billion") to 2022 reporting, yet the same "2 million... 78 countries" phrasing reappears in a 2026 article on the same subject.⁷² Whether that reflects a genuinely flat patient count for four straight years or, more likely, an industry statistic being recycled without being re-measured is impossible to tell from the public reporting — but it's a reason to treat any single India patient-volume figure as an estimate with a wide, largely undisclosed error bar rather than a precise count.

Malaysia: the most tightly reported growth story in the region

Malaysia's numbers are the cleanest in this comparison because they come from a single body — the Malaysia Healthcare Travel Council (MHTC) — reporting both patient counts and revenue for the same years. MHTC's own 2024 figures show 1.6 million healthcare travellers, a 14% year-on-year increase, generating RM2.72 billion in revenue, itself up 21% from 2023.⁴ Off the back of that, MHTC launched "MYMT 2026" (Malaysia Year of Medical Tourism), a national campaign built around the tagline "Healing Meets Hospitality" with singer Dato' Seri Siti Nurhaliza as ambassador, explicitly aimed at converting 2024's momentum into MHTC's stated goal of RM12 billion in industry revenue by 2030 — meaning the council is targeting roughly 4.4x its 2024 revenue within six years.⁴ The campaign also spotlighted a "Flagship Medical Tourism Hospital" designation shortlisting four hospitals — Institut Jantung Negara, Island Hospital Penang, Mahkota Medical Centre, and Subang Jaya Medical Centre — with a winner due in December 2025.⁴

Thailand, South Korea, and Vietnam: three different specializations

The remaining three fast-growing markets each compete on a different axis rather than duplicating India's or Malaysia's model. Thailand, already the region's most JCI-dense destination with more than 60 accredited hospitals, drew 1.2 million patients and $850 million in revenue in 2024 under its 2025–2034 national medical-hub strategy, which explicitly names aesthetic medicine, IVF, gender-affirming care, and dental treatment as target service lines rather than pursuing every specialty at once.⁵ South Korea, with 1.17 million foreign patients in 2024, is even more concentrated by specialty: dermatology alone accounts for 56.6% of its international treatment volume, underscoring that Korea's medical-tourism growth is substantially a cosmetic- and skin-treatment story rather than a broad-based hospital-care one.⁵ Vietnam is the outlier on the growth axis rather than the volume one — it doesn't yet appear in these reports' absolute patient-count rankings, but is projected to be the single fastest-growing country in the region at an 18.51% CAGR through 2031, backed by a stated government target of reaching 1 million medical tourists by 2030.⁵

Why the region is outgrowing the rest of the world, not just growing

Coherent Market Insights attributes the region's above-average CAGR to a specific combination rather than any single factor: a structural cost advantage over Western providers, expanding healthcare-facility capacity, relaxed medical-visa procedures, rising international accreditation, and — critically — simultaneous, named government investment programs rather than organic private-sector growth alone.¹ What the country-level data above adds to that summary is that the "government investment" driver isn't evenly distributed or identically designed: India is building broad new physical infrastructure (five hubs) aimed at volume and visa access; Malaysia is running a single coordinated national marketing and revenue-target campaign; Thailand is picking specific service lines to specialize in; and Vietnam is setting a public numeric patient target well before it has built out comparable capacity. That variety is itself informative — it suggests the region's 15.4% figure isn't one replicable playbook succeeding four times, but four different bets that happen to be paying off in the same three-year window.

The caveat that applies to every number above

As with medical-tourism market-size figures generally, these regional and country totals come from research firms and government-linked tourism bodies with a direct interest in reporting growth, and — as this same publication has covered separately when comparing global 2026 market-size estimates that vary sixfold by definition and scope — "medical tourism," "healthcare traveller," and "international patient" are not standardized terms across these reports.¹²⁴⁵ India's own numbers make the point concretely: a single country's foreign-patient count is reported anywhere from 644,000 to 7.3 million depending on which body counted it and what it counted as "medical," an eleven-fold spread within one country in one year.²⁶ The safest way to use the table above is as a directional comparison of which countries are growing and by roughly how much, not as a precise, mutually consistent accounting of the region's total patient volume.

Footnotes

1. https://www.coherentmarketinsights.com/market-insight/medical-tourism-market-938 ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

2. https://www.outlooktraveller.com/News/union-budget-2026-from-ayurveda-to-advanced-care-india-targets-global-patients-with-medical-tourism ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹²

3. https://medicaltourismwatch.com/countries-most-jci-accredited-hospitals/ ↩

4. https://www.mhtc.org.my/malaysia-healthcare-travel-council-launches-mymt-2026-malaysias-first-medical-tourism-year/ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

5. https://www.mordorintelligence.com/industry-reports/asia-pacific-medical-tourism-market ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹²

6. https://www.ibef.org/news/number-of-medical-tourists-in-india-to-exceed-pre-pandemic-levels-in-cy24 ↩ ↩²

7. https://en.wikipedia.org/wiki/Medical_tourism_in_India ↩

Show all 7 sources